AEG-1 is associated with tumor progression in nonmuscle-invasive bladder cancer

被引:0
|
作者
Guoliang Yang
Lianhua Zhang
Shilong Lin
Linfeng Li
Mengyao Liu
Haige Chen
Ming Cao
Dongming Liu
Yi-ran Huang
Juanjie Bo
机构
[1] Shanghai Jiao Tong University,Department of Urology, Ren Ji Hospital
[2] Shanghai Jiao Tong University,Clinical Stem Cell Research Center, Ren Ji Hospital
来源
Medical Oncology | 2014年 / 31卷
关键词
AEG-1; Bladder cancer; Prognosis; Progression;
D O I
暂无
中图分类号
学科分类号
摘要
Astrocyte elevated gene-1 (AEG-1), a novel oncoprotein, has been implicated in oncogenesis and cancer progression in various types of human cancers. Here, immunohistochemistry was used to detect AEG-1 expression in nonmuscle-invasive bladder cancer (NMIBC), and these data were examined for correlation with clinicopathological parameters, and prognosis. Immunohistochemical analysis revealed that AEG-1 expression was significantly higher in bladder cancer tissues than that in normal tissues. High expression of AEG-1 was found in 45 % of bladder cancers and significantly associated with tumor grade (P = 0.002) and progression (P = 0.028). The Kaplan–Meier survival analysis demonstrated that AEG-1 expression was significantly associated with shorter progression-free survival (P = 0.0011). Multivariate analysis further demonstrated that AEG-1 was an independent prognostic factor for patients with BC. AEG-1 protein may contribute to the malignant progression of bladder cancer, and present as a novel marker to predict the progression of NMIBC.
引用
收藏
相关论文
共 50 条
  • [11] Nonmuscle-invasive bladder cancer (NMIBC): when to perform cystectomy?
    Lebret, Thierry
    PROGRES EN UROLOGIE, 2008, 18 : S111 - S114
  • [12] Therapy of low-grade nonmuscle-invasive bladder cancer
    Olbert, P. J.
    Ohlmann, C. H.
    Schwentner, C.
    UROLOGE, 2015, 54 (04): : 484 - 490
  • [13] The role of MTDH/AEG-1 in the progression of cancer
    Shi, Xue
    Wang, Xin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 4795 - 4807
  • [14] Nonmuscle-invasive bladder cancer, old problems, new insights
    Comperat, Eva
    Wasinger, Gabriel
    Oszwald, Andre
    Pradere, Benjamin
    Shariat, Shahrokh
    CURRENT OPINION IN UROLOGY, 2022, 32 (04) : 352 - 357
  • [15] QUALITATIVE ASSESSMENT OF PAIN IN NONMUSCLE-INVASIVE BLADDER CANCER SURVIVORS
    Goltz, Heather H.
    Kowalkowski, Marc A.
    Amiel, Gilad E.
    Lerner, Seth P.
    Latini, David M.
    ANNALS OF BEHAVIORAL MEDICINE, 2012, 43 : S165 - S165
  • [16] Recent improvements in the detection and treatment of nonmuscle-invasive bladder cancer
    Kausch, Ingo
    Doehn, Christian
    Jocham, Dieter
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (09) : 1301 - 1311
  • [17] Predicting recurrence and progression in Australian patients with nonmuscle-invasive bladder cancer using the EORTC scoring model
    Demkiw, S.
    Mow, T.
    Duggan, G.
    Goad, J.
    Wong, L-M.
    BJU INTERNATIONAL, 2015, 115 : 56 - 56
  • [18] Patient and Provider Perception of Transurethral Resection of Bladder Tumor vs Chemoablation for Nonmuscle-invasive Bladder Cancer Treatment
    Parisse, Taylor
    Reines, Katy
    Basak, Ramsankar
    Mueller, Dana
    Teal, Randall
    Vu, Maihan B.
    Carda-Auten, Jessica
    Stein, Kathryn
    Giannone, Kara
    Lipman, Robert
    Smith, Angela B.
    JOURNAL OF UROLOGY, 2023, 209 (01): : 150 - 159
  • [19] Biology of nonmuscle-invasive bladder cancer: pathology, genomic implications, and immunology
    Dyrskjot, Lars
    Ingersoll, Molly A.
    CURRENT OPINION IN UROLOGY, 2018, 28 (06) : 598 - 603
  • [20] The Multifaceted Role of MTDH/AEG-1 in Cancer Progression
    Hu, Guohong
    Wei, Yong
    Kang, Yibin
    CLINICAL CANCER RESEARCH, 2009, 15 (18) : 5615 - 5620